Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    RLS.ST Net Margin

    As of 2025-05-15, the Net Margin of RLS Global AB (RLS.ST) is -2034%.

    Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

    RLS.ST Net Margin - Historical Value
    DateValue
    2022-12-31 -2034%
    2021-12-31 -1721.1%
    2020-12-31 -1099.4%
    2019-12-31 -2642.8%
    2018-12-31 -835.6%
    2017-12-31 -827.4%
    2016-12-31 -477.6%
    2015-12-31 -420.6%
    2014-12-31 -981.3%
    -
    RLS.ST Net Margin - Peers Comparison
    TickerNameValue
    ACPH.BRAcacia Pharma Group PLC-5781.9%
    ADVIC.PAAdvicenne SA-720%
    AGY.LAllergy Therapeutics PLC-72.9%
    AMYT.LAmryt Pharma PLC-57.2%
    CLBIO.STCorline Biomedical AB-237.3%
    EAH.LECO Animal Health Group PLC1.2%
    ENZY.STEnzymatica AB (publ)-116.7%
    ERMA.STEnorama Pharma AB-277.8%
    FCM.MIFriulchem SpA-0.9%
    HYL.BRHyloris Pharmaceuticals SA-546.6%
    IBT B.STInfant Bacterial Therapeutics AB-15191.6%
    INDEX.STInDex Pharmaceuticals Holding AB-97.7%
    IRLAB A.STIRLAB Therapeutics AB-87.8%
    KDEV.STKarolinska Development AB-440.8%
    LAVI.ATLavipharm SA17%
    LIPI.STLipidor AB-98614.3%
    MARI.VIMarinomed Biotech AG-74%
    MOB.STMoberg Pharma AB (publ)-2600.3%
    N4P.LN4 Pharma PLC-65475.9%
    NUTEX.BDNutex Befektetesi Nyrt38027.6%
    OAT.WAOncoarendi Therapeutics SA52.3%
    ORX.STOrexo AB-34.4%
    OVB.LOvoca Bio PLC-
    PHO.OLPhotocure ASA-0.6%
    PRL.MIPierrel SpA5.6%
    SHE.MIShedir Pharma Srl Unipersonale9.6%
    VISTN.OLVistin Pharma ASA14.6%
    ZICC.STZiccum AB-571.4%
    Tickers added to watchlist